S&P Little Changed After Powell Remarks
Stocks were little changed on Tuesday as investors digested cautious commentary from Federal Reserve Chairman Jerome Powell on interest rates. Concerns remain over the direction of the economy amid U.S. tariffs and the possible escalation of a global trade war.The Dow Jones Industrials moved into the green 55.95 points, to 44,526.36The S&P 500 slid 0.63 points to 6,065.81The tech-heavy NASDAQ dipped 27.81 points to 19,685.69 Apple gained more than 2.5% on a report that the company is partnering with Alibaba to develop AI features for iPhone users in China, curbing the market’s losses. Coca-Cola also jumped about 3% on a strong earnings report.Powell earlier addressed the Senate Banking Committee and signaled the Fed does not need to move quickly to ease monetary policy.Trump on Monday signed new tariffs on all steel and aluminum imports to the U.S. The European Union responded by saying it would retaliate with levies of its own if the U.S. tacks on tariffs against products from the country bloc. Prices for the 10-year Treasury retreated slightly, raising yields to 4.53% from Monday’s 4.50%. Treasury prices and yields move in opposite directions.Oil prices tacked on 71 cents to $73.03 U.S. a barrel. Prices for gold tailed off $3.50 an ounce to $2,930.90 U.S.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


